M osquito-borne flaviviruses such as dengue virus (DENV) and Zika virus (ZIKV) severely impact global health with an estimated 100 million individuals suffering from DENV-induced illness alone 1,2 . Gaining insights into the mechanisms by which flaviviruses exploit their host environment to promote viral propagation could yield targets for host-directed therapies to combat infections 3,4 . Flaviviruses enter cells through receptor-mediated endocytosis and following membrane fusion the viral genomes are released into the cytoplasm. The approximately 11 kilobase (kb) flavivirus genomic RNA encodes a single viral polyprotein, which is subsequently cleaved into mature structural and non-structural proteins. Biogenesis of the flaviviral proteins, which occurs at endoplasmic reticulum (ER) membranes, is not trivial due to the size of the polyprotein (approximately 3,300 amino acids), the occurrence of multiple transmembrane regions, and the cotranslational cleavage by viral and cellular proteases. After an initial round of translation, the RNA serves as a template for RNA replication, which occurs in close association to the ER membrane and primarily requires the NS5 RNA-dependent polymerase and NS3 helicase with involvement of other non-structural proteins and poorly defined host factors. The viral RNA-protein interactions are essential for recruiting and retaining the RNA at these ER sites, and for mobilizing the cellular factors required for translation, replication and packaging 5-7 . Although the viral RNA (vRNA) constitutes a central molecular hub during flavivirus infection, the precise molecular details have yet to be unravelled 8 . A global survey of cellular RNA-binding proteins (RBPs) interacting with vRNAs during infection would provide molecular insights into the composition and function of the ribonucleoprotein machines that drive vRNA translation and replication. Flaviviruses, including dengue virus (DENV) and Zika virus (ZIKV), cause severe human disease. Co-opting cellular factors for viral translation and viral genome replication at the endoplasmic reticulum is a shared replication strategy, despite different clinical outcomes. Although the protein products of these viruses have been studied in depth, how the RNA genomes operate inside human cells is poorly understood. Using comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS), we took an RNA-centric viewpoint of flaviviral infection and identified several hundred proteins associated with both DENV and ZIKV genomic RNA in human cells. Genome-scale knockout screens assigned putative functional relevance to the RNA-protein interactions observed by ChIRP-MS. The endoplasmic-reticulum-localized RNA-binding proteins vigilin and ribosome-binding protein 1 directly bound viral RNA and each acted at distinct stages in the life cycle of flaviviruses. Thus, this versatile strategy can elucidate features of human biology that control the pathogenesis of clinically relevant viruses.
Results
Unbiased discovery of the flaviviral genomic RNA-protein interactome. To define the compendium of host proteins that associate with the positive-strand vRNA, we implemented comprehensive identification of RBPs by mass spectrometry (ChIRP-MS) 9 . The human hepatoma cell line Huh7.5.1, which supports high levels of flaviviral replication, was infected with either DENV-2 or ZIKV at a multiplicity of infection (m.o.i.) of 0.1 for 48 h. The infected cells were subsequently crosslinked with formaldehyde to preserve the in-cell interactions between proteins and RNAs and stabilize the ribonucleoprotein complexes. Biotinylated oligonucleotides (Supplementary Table 1 ) were used to specifically enrich for DENV or ZIKV RNA and the recovered proteins were subjected to labelfree quantitative liquid chromatography with tandem mass spectrometry (LC-MS/MS; Fig. 1a ). We recovered roughly 50% of the vRNA across the full length of each vRNA, suggesting robust sampling of the total cellular vRNAs, while strongly depleting highly abundant host RNAs such as 7SK and ribosomal RNA, as shown by analysis of the quantitative PCR with reverse transcription (qRT-PCR; Supplementary Fig. 1a ). The tiled probes were also able to capture full-length DENV-2 RNA from the total RNA of infected Huh7.5.1 cells while depleting all other cellular RNAs ( Supplementary Fig. 1b,c) . Together, these experiments provide strong evidence that ChIRP enrichment for DENV and ZIKV RNA is specific and efficient.
Investigation of the ChIRP-MS revealed extensive coverage of both DENV and ZIKV polyproteins including the structural (C, PrM and E) and non-structural (NS1-NS5) viral proteins ( Fig. 1b-d) . Analysis of the peptide coverage per protein length revealed that the viral NS3 and NS5 were the most abundant recovered proteins ( Supplementary Fig. 1d ), which is consistent with these being RBPs that directly bind the flaviviral RNA. Our results are thus in line with ChIRP-MS enriching most strongly for RBPs but also for proteins present in functionally relevant RNA-protein complexes that do not directly interact with the RNA 10 .
In addition to the virally encoded polyproteins, we identified 464 high-confidence hits from the human proteome that were specifically and reproducibly associated with DENV or ZIKV vRNA (false-discovery rate (FDR) < 0.01, SAINT score >0.99 and enrichment >2 fold over the uninfected control ChIRP-MS; Fig. 1e , Supplementary Table 2 and Methods). The ChIRP-MS was highly consistent across the biological triplicates, confirming a strong intra-probe set reproducibility ( Supplementary Fig. 1e ,f). The enrichment of specific host factors recovered with DENV or ZIKV RNA were positively correlated (Pearson's r = 0.67; Fig. 1e ). RNAbinding proteins previously implicated in the antiviral response against DENV infection-including MOV10 (ref. 11 ), YBX1 (ref. 12 ) and ADAR 13 -as well as proteins with pro-viral functions, such as SND1 (ref. 14 ) , were among the highest-scoring candidates. Gene Ontology annotation revealed the strongest enrichment for the membrane component of cells ( Fig. 1f ). Protein-domain analysis of the hits was enriched for RNA-binding domains and the majority of the hits (approximately 75%) overlapped with a comprehensive list of mammalian RBPs 15 ( Fig. 1g and Supplementary Table 2 ). Given the role of the ER membrane in flaviviral translation and the Gene Ontology enrichment, we examined ER-localized proteins in the ChIRP-MS data. The ER-localized proteins were enriched with high statistical significance (P < 0.0001, Fischer's exact test) in the ChIRP-MS dataset (31/464) when compared with the fraction of ER-localized proteins expressed in Huh7.5.1 cells (421 /18,199; Methods and Supplementary Tables 3, 4) . These data reinforce the idea that ChIRP-MS retrieves RBPs that associate with flaviviral RNA and that several of these are ER-proteins.
To determine the specificity of the RBPs for flaviviruses, we performed ChIRP-MS on an unrelated single-stranded RNA virus from the picornavirus family (rhinovirus (RV), strain RV-B14). We recovered 350 host proteins associated with rhinovirus RNA (Supplementary Table 5 ). A comparison between the host proteins associated with DENV or ZIKV and RV-B14 vRNA resulted in a weaker pairwise correlation ( Supplementary Fig. 2a ,b; Pearson's r = 0.40 and 0.13, respectively) than between the two flaviviruses. Further, RV did not statistically enrich for ER-annotated factors (5/350 hits; Supplementary Fig. 2c and Supplementary Table 3 ), underscoring the important role the ER membrane plays in flaviviral biology. Thus, the DENV and ZIKV ChIRP-MS experiments provide a valuable resource of host factors that associate with flaviviral positive-strand RNA.
Genome-wide knockout screens reveal functional ChIRP-MS host factors. We and others have previously reported genome-wide knockout (KO) screens for DENV-2 (type strain 16681), ZIKV (African type strain MR766) and West Nile virus [16] [17] [18] [19] . Here, we provide a higher granularity view to these studies by interrogating multiple serotypes and clinical isolates. We performed four clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 (Cas9) screens in Huh7.5.1 cells by infecting them with four recently isolated and low-passaged DENV serotypes (that is, 1, 2, 3, and 4). For ZIKV, we performed haploid genetic screens utilizing three ZIKV strains isolated during recent epidemics in French Polynesia (FP/13), Puerto Rico (PRVABC59) and Colombia (FLR). The screen results were consistent and reproducible across the DENV serotypes and ZIKV strains (Supplementary Table 6 ). We merged the enrichment scores of the respective DENV ( Fig. 2a ) and ZIKV ( Supplementary Fig. 3a ) screens to obtain core sets of genes critical for flavivirus infection. Most of the identified host factors and pathways were related to the biogenesis of ER-targeted proteins and were common between DENV and ZIKV ( Supplementary Fig. 3b ,c and Supplementary Table 6 ). Collectively, these data represent a saturating analysis of host factors through seven genome-wide KO screens and highlight the importance of specific intracellular ER-associated protein complexes for DENV and ZIKV infection.
Because the DENV forward genetic screens and the ChIRP-MS were performed in the same Huh7.5.1 cell line, we compared these orthogonal techniques. Intersection of the top-200 hits from the DENV KO screens with the ChIRP-MS resulted in ten co-occurring proteins ( Fig. 2b and Supplementary Table 6 ). Several subunits of the OST complex (STT3A, STT3B, RPN2 and MAGT1) were top hits in this dataset, both associating with the vRNA and of central importance for viral replication 16 (Fig. 2b ). ASCC3 and SND1 were previously described to be important as a regulator of the cellular transcriptional response to flavivirus infection and as directly binding to vRNA, respectively 14, 20 . Finally, two factors, vigilin and ribosome-binding protein 1 (RRBP1), that have not been previously linked to flavivirus infection stood out as among the most enriched in the ChIRP-MS (Supplementary Table 2 and Fig. 2b ). We therefore focused on characterizing the molecular properties of these RBPs as well as defining the stages of the flaviviral life cycle at which these RBPs act.
To assess the impact of RRBP1 and vigilin on flaviviral infections, we generated isogenic KO lines (RRBP1-KO and vigilin-KO) in Huh7.5.1 cells ( Fig. 2c ). We then challenged RRBP1-KO and vigilin-KO cells with DENV, ZIKV and Powassan virus (POWV)all of which belong to the flavivirus genus-or Chikungunya virus (CHIKV), an alphavirus. The vRNA loads were significantly reduced in the KO cells for most of the tested flaviviruses but the RNA levels of CHIKV were unaffected ( Fig. 2d,e ). The reduction of ZIKV infectivity in the KO cells was further validated using a luciferase-expressing ZIKV (ZIKV-Luc; Supplementary Fig. 3d ). Thus, RRBP1 and vigilin are broadly required for members of the mosquito-borne (DENV and ZIKV) and tick-borne (POWV) flaviviruses but not for the unrelated arbovirus CHIKV. The abundance of viral proteins (for example, prM and NS3) was noticeably decreased in RRBP1-KO and vigilin-KO cells (Fig. 2f ). The absence of RRBP1 and vigilin also led to a significant decrease in the production of infectious progeny virions (Fig. 2g ). These results solidified RRBP1 and vigilin as host factors that promote flavivirus infections. RRBP1 and vigilin interact at the ER. RRBP1/p180 is a highly expressed RBP anchored to the ER via a N-terminal transmembrane domain that can act as a messenger RNA receptor at the ER 21 . Vigilin promotes the translation of a subset of secretory mRNAs at the ER but, in contrast to RRBP1, lacks a transmembrane domain to anchor it to the ER 22 . Confocal microscopy revealed that both RRBP1 and vigilin co-localized with ER-green fluorescent protein (GFP), a previously reported ER marker 23 , with RRBP1 exhibiting a slightly higher correlation than vigilin (0.69 and 0.60, respectively; Fig. 3a and Supplementary Fig. 4a ). To assess the association with ER membranes more directly, we used a subcellular fractionation assay, which relies on a mild digitonin lysis to separate ER membranes from the cytosolic contents 24 . RRBP1 exclusively co-fractionated with the ER fraction, whereas vigilin was found in both the ER and cytosolic fractions ( Fig. 3b ). To test whether RRBP1 and vigilin associate with each other, we performed co-immunoprecipitation (co-IP) experiments. We found that vigilin co-immunoprecipitated with RRBP1 in uninfected and DENV-infected cells ( Fig. 3c and Supplementary Fig. 4b ). Treatment with RNase A markedly reduced the co-recovery of vigilin with RRBP1, suggesting that this interaction was RNA dependent ( Fig. 3c and Supplementary  Fig. 4b ). Finally, during infection with DENV and ZIKV, both proteins co-localized with positive-stranded vRNA (Fig. 3d,e and Supplementary Fig. 4c,d ). Together, our data indicate that RRBP1 and vigilin interact in an RNA-dependent manner at the ER close to the positive-stranded vRNA.
Global characterization of RNAs associated with RRBP1 and vigilin.
To examine the interaction of RRBP1 and vigilin with viral and cellular RNA during infection, we performed infrared crosslinking and immunoprecipitation (irCLIP) 25 on uninfected and virus-infected cells. Primary antibodies targeting RRBP1 and vigilin generated an irCLIP RNAse-sensitive signal that was specific to their respective RBPs ( Supplementary Fig. 5a,b ). Further, mass-spectrometry a   TAX1BP3  CPA6  PRKRA TIRAP  KAT6B  KLRC4  RAB38  (MINDY3)  B4GALT1  C12orf56   HSPA13   SSR2  SSR4  TRAM1  ASCC3  SND1  SPCS3  RRBP1  APOB  OST4  ASCC2   EMC6  MMGT1  EMC1  SSR3   MAGT1  EMC4  EMC3   SSR1   EMC2  HDLBP  STT3A   STT3B   RPN2  EMC8  OSTC  UBE2J1  HM13  DERL2   EMC7   CACNA1G SPCS2  LPIN2  TXNDC5  RAB5A  TMEM41B  PRKCSH  FAM98A  GIPC3   FAM188A analysis of proteins co-enriched with RRBP1 or vigilin irCLIP enrichments near their molecular weight confirmed their specificity ( Supplementary Fig. 5c,d ). Sequencing of the enriched RNAs revealed that RRBP1 had a preference for binding ribosomal RNA (66% rRNA) over messenger/non-coding RNA (33% mRNA/ncRNA; Fig. 4a ), which is in line with its known direct association with ribosomes 26 . RRBP1 crosslinks to many sites across rRNAs with a strong peak in the 18S rRNA on helix 18 (H18) positioned near the mRNA entry channel 27 (Fig. 4b) . In contrast to RRBP1, the vigilin reverse-transcriptase (RT) stops mapped mainly to mRNA/ncRNAs with only a minor contribution of rRNA ( Fig. 4a ). Interestingly, although vigilin has a more restricted rRNA-binding pattern, its major binding site is on H16 of the 18S rRNA, adjacent to the RRBP1-bound position at the mRNA entry channel (Fig. 4b ).
Infection with DENV or ZIKV resulted in the appearance of reads derived from the viral positive-stranded genome for both RRBP1 and vigilin. The change in binding profile was especially apparent for vigilin, where 75% and 49% of all crosslinks mapped to the vRNA of DENV and ZIKV, respectively ( Fig. 4a ). Globally, for both RRBP1 and vigilin, RT stops mapping the mRNAs were depleted in intronic regions, suggesting a preference for mature transcripts (Fig. 4c ). Vigilin preferentially bound exonic regions, whereas RRBP1 binding was enriched for binding to exons as well as to the 5′ and 3′ untranslated regions (UTRs; Fig. 4c ). For both RRBP1 and vigilin, Gene Ontology analysis of the bound mRNAs revealed terms related to membrane-bound and secreted proteins known to be highly expressed in hepatic cells (Supplementary Tables 7 and 8) 28, 29 . For RRBP1, in the context of infection, there was weaker enrichment for membrane terms, whereas there was a gain of novel terms such as cytosol and ribosome, suggesting differential localization of these mRNAs following infection ( Supplementary  Fig. 5e ). For vigilin, the enrichments were quite similar between infected and uninfected cells ( Supplementary Fig. 5f ).
We next visualized the RT stops mapping to DENV or ZIKV RNA. RRBP1 crosslinked across the full-length positive-strand vRNA with RT stops extending into the 5′ and 3′ UTRs ( Fig. 4d and Supplementary Fig. 6a ). In contrast, vigilin bound to the coding region but markedly fewer RT stops were observed in the 5′ and 3′ UTRs (Fig. 4d ). This pattern was similar to what was observed with cellular mRNAs ( Fig. 4c and Supplementary Fig. 6b ,c) and is in line with the previously reported preference for binding to coding regions 22 . We observed rather uniform binding throughout the vRNA without apparent hotspots for both RBPs. On a per nucleotide basis, RRBP1 and vigilin binding was positively correlated on the DENV and ZIKV genomes (r = 0.79 and 0.84, respectively; Supplementary Tables 7 and 8) but did not correlate to complementary DNA truncations from RNA sequencing (RNA-seq) of the vRNA, which suggests that the irCLIP profiles are specific ( Supplementary Tables 7 and 8 ). This broad 'coating' of the vRNA is reminiscent of how other RBPs, such as FMRP, bind actively translating mRNAs 30 . Together, the comparative RNA-binding profiles of RRBP1 and vigilin show that both proteins engage cellular rRNA and secretory mRNAs, with RRBP1 demonstrating a higher proportion of rRNA binding. During infection, both RBPs bind flavivirus RNA and the majority of RT stops retrieved for vigilin are of flaviviral origin.
RRBP1 and vigilin are required for the optimal translation and replication of DENV. We further defined the step(s) at which the RBPs act in the viral life cycle by utilizing a luciferase-expressing DENV (DENV-Luc). First, we generated additional RRBP1 and vigilin clonal KO HEK293 cell lines to mitigate potential cell-type-specific effects ( Supplementary Fig. 7a,b ). RRBP1 and vigilin deficiency resulted in decreased luciferase expression throughout the infection cycle for DENV-Luc but not for the unrelated Coxsackievirus B3 virus expressing luciferase ( Fig. 5a-d ). Re-expression of RRBP1 and vigilin rescued, at least partially, the defect in flavivirus translation and replication, indicating that it is specific to the KO. To separate the translation and replication phase of the viral life cycle from the viral entry and uncoating steps, we transfected in vitro transcribed DENV replicon, in which the structural proteins are replaced with the Renilla luciferase gene. Compared with wild-type (WT) cells, the KO of both RBPs resulted in decreased luciferase expression throughout the time course ( Fig. 5e ,f). Because viral entry was bypassed in this experiment, these results suggest that RRBP1 and vigilin promote optimal viral translation and replication rather than viral entry. Viral translation and replication are intricately linked: after the initial translation, viral non-structural proteins are produced that replicate genomic RNA, which in turn produces more mRNA templates resulting in increased translation. A larger contribution of initial translation is expected early in infection, whereas it is a combination of viral translation and replication at later time points. We performed DENV-Luc infections in the presence or absence of the DENV RNA replication inhibitor MK0608 31 to examine this in more detail and to assess the respective contributions of RRBP1 and vigilin to these phases. Control experiments confirmed that the luciferase signal at 8 h post-infection (h.p.i.) in the presence of MK0608 represents initial viral translation, whereas the bulk of the signal at 36 h.p.i. (in the absence of MK0608) is due to the subsequent RNA replication and translation ( Supplementary Fig. 7c,d ). Compared with the WT, RRBP1 deficiency resulted in an approximately twofold reduction of luciferase expression at 8 h.p.i., whereas vigilin deficiency did not decrease luciferase expression ( Fig. 5g ). However, vigilin-KO showed a more severe phenotype than RRBP1-KO at 36 h.p.i. (7× versus 3× reduction, respectively). We therefore conclude that the role of RRBP1 is more pronounced during the early stages of infection, whereas vigilin plays a more significant role at the later stages of infection.
Cellular RBPs contribute to DENV genomic RNA stability. We generated an isogenic cell line that is deficient in both RRBP1 and vigilin in Huh7.5.1 cells to further characterize the role of RRBP1 and vigilin ( Fig. 6a ). We observed a greater decrease in luciferase expression in the single RRBP1-KO cells compared with vigilin-KO cells early in infection and the reverse pattern later in infection with DENV-Luc, corroborating the RBP-KO viral phenotypes in HEK293 cells (Fig. 5g ). The RRBP1-vigilin double-KO cells displayed an early defect comparable to RRBP1-KO cells and a late defect that was stronger than that observed for vigilin-KO cells ( Fig. 6b ), suggesting that both RBPs are required for optimal replication. Our results combined with the known role of RRBP1 and vigilin in the translation of cellular mRNAs 32, 33 suggest that the RBPs stimulate vRNA replication, at least partially, by promoting translation of the viral polyprotein. In addition to translation, both vigilin and RRBP1 can also act on the stability of their target mRNAs 34, 35 . To assay for vRNA accumulation, we used MK0608 to inhibit viral replication and northern blotted against the DENV 3′ UTR, which allows the detection of vRNA decay (Fig. 6c ). We observed that the accumulated DENV genomic RNA was relatively stable in the WT cells for up to 24 h following MK0608 treatment ( Fig. 6c and Supplementary Fig. 8a ). In contrast, the decay rate of the genomic RNA was accelerated in the absence of both RRBP1 and vigilin ( Fig. 6c and Supplementary. 8b). Together, our data indicate that RRBP1 and vigilin promote optimal flavivirus infection and have roles in vRNA translation, replication and stability.
Discussion
Our results provide detailed insights into the molecular identity of the host machineries engaged by flaviviral RNA during infection. We have comprehensively mapped the interactions between the flaviviral RNA genome and the human cellular proteome during viral infection using ChIRP-MS. Intersecting this dataset with a core set of genes identified in our genetic screens using all serotypes of DENV and multiple strains of ZIKV ( Supplementary Table 9 ) highlighted the importance of ER-localized RBPs for flavivirus infection. One example of an ER-localized RBP was RRBP1-which has a short luminal domain, a transmembrane domain, and a large domain facing the cytosol that is highly basic and contains a decapeptide tandem-repeat motif 36 . RRBP1 can act as a minor polysome receptor at the ER membrane 37 and it can also bind certain mRNAs in a ribosome-independent fashion 33 . Our data support these nonmutually exclusive views of RRBP1 function: the majority of RT stops identified from the RRBP1 irCLIP are indeed from the rRNA but nearly one-third of binding maps to mRNAs enriched for secretory protein transcripts (for example, APOB and AFP).
Vigilin is an evolutionarily conserved RBP that interacts with RNA through its KH domains. Although vigilin has been reported to be predominantly cytosolic, associating with free ribosomes 38 , we detected a portion of vigilin in the ER fraction, thus corroborating previous observations of its association with ribosomes at the rough ER 39, 40 . We found that vigilin directly binds to rRNA and is preferentially enriched for binding to a subset of cellular mRNAs that encode secretory proteins, indicating a potential role in translation. This is consistent with the emerging view of vigilin as a translational enhancer for a subset of mRNAs of the secretory pathway 22, 41 . Our results indicate that DENV and ZIKV co-opt vigilin to promote infection.
Determining the protein interactome of RNA viruses has been a long-standing question of the field and is of interest to many laboratories. Two recent reports that utilized ultraviolet (UV) crosslinking and DENV RNA pulldown 42,43 found 12 and 93 host RBPs, respectively, that partially overlap with our ChIRP-MS data ( Supplementary Table 10 ). We used ChIRP-MS as a robust platform to discover the protein interactomes of vRNA. We were careful to verify that the enrichment procedure would recover proteins binding across the entire length of the 11-kb viral genome as well as sample a majority of the vRNA from infected cells. These quality controls ensured that the resulting proteomic data would be as robust and complete as possible. Further, as a discovery tool, we opted for chemical crosslinking, which provides the context of RBP complexes associated with the target RNA.
Our study of the flavivirus RNA interactome is a valuable resource that provides an RNA-centric perspective on viral infection, complementing other large-scale approaches that map virus-host interactions. The strategy employed here, integrating RNA-protein interactome data with genome-scale KO screening, is a generalizable strategy for the study of the complex interactions of cellular proteins with other RNA viruses. Critically, rigorous validation through isogenic KO of host factors and direct but unbiased assessment of their RNA interactomes with irCLIP provides a robust platform for the discovery of functional interactions. The approach emphasizes the RBPs that have a pro-viral role because of the design of the genetic screens but can readily be modified to include other large-scale approaches that identify proteins with antiviral activities 44 .
Methods
Cell lines, reagents and generation of KO cells. HAP1 cells were derived from the near-haploid chronic myeloid leukaemia cell line KBM7 (ref. 45 ). The HAP1 cells were cultured in IMDM medium supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS), penicillin-streptomycin and l-glutamine. BHK-21 (ATCC), HEK293FT (Thermo Fischer Scientific), H1-HeLa cells (ATCC), Huh7.5.1 (gift from F. Chisari), RD (ATCC), BHK-21 (ATCC), Vero (ATCC) cells and their KO derivatives were cultured in DMEM media supplemented with 10% HI-FBS, 1×penicillin-streptomycin and 1×l-glutamine. C6/36 cells (ATCC) were purchased from the ATCC and cultured in Leibovitz's L-15 medium supplemented with penicillin-streptomycin, l-glutamine and 10% HI-FBS. Cycloheximide was purchased from Sigma-Aldrich. MK0608 (7-deaza-2'-C-methyladenosine) was purchased from Carbosynth. A CRISPR-Cas9 strategy was employed to generate RRBP1-and vigilin-KO cell lines. CRISPR guide RNA sequences were designed using the Zhang lab CRISPR design tool (http://crispr.mit.edu) and the corresponding oligos were purchased from Integrated DNA Technologies. The oligos were cloned into the Cas9-expressing pX458 guide RNA plasmid (Addgene, cat. no. 48138) generated by the Zhang lab as previously described 16 . The cloning products were transfected into HEK293FT and Huh7.5.1 cells using Lipofectamine 3000 (Thermo Fisher Scientific) and subsequently single-cell sorted based on GFP expression into 96-well plates using a BD Influx cell sorter at the Stanford Shared FACS facility. Clonal cell lines were allowed to expand from a single cell and genomic DNA was isolated for sequencing-based genotyping of targeted alleles. For this, a 300-500 base-pair region that encompassed the guide-RNA-targeted site was amplified and the sequence of the PCR product was determined by Sanger sequencing. Subclones were chosen where all alleles were mutated with insertions or deletions that were not a factor of three. Knock-out subclones verified by genotyping were further confirmed by western blotting using antibodies against RRBP1 (Bethyl Laboratories, A303-996A) or vigilin (Bethyl Laboratories, A303-971A). The guide RNA primers are listed in Supplementary Table 1 The POWV LB-prototype-strain (originally obtained from R. Tesh, University of Texas Medical Branch) 46 stock was amplified and titred by a standard plaque assay in Vero cells.
The luciferase-encoding ZIKV infectious clone (ZIKV-Rluc) was provided by P.-Y. Shi, (UTMB) and the viral stock was generated in Vero cells as described 47 . The Coxsackievirus B3 Nancy strain that encodes Renilla luciferase (CVB3-Luc) was a gift from F. v. Kuppeveld and was propagated by transfection of the infectious clone pRLuc-53CB3/T7 into RD cells 48 . The titre of CVB3-Luc was determined by a standard plaque assay on H1-HeLa cells.
Construction of the pDENV-Luc infectious clone was performed as described 16 . The viral 5′ UTR was followed by a duplication of the first 104 nucleotides of the C coding region, which contains cis-acting elements required for replication (CAE). The CAE was fused to the Renilla luciferase coding region followed by the complete DENV open reading frame (ORF). A foot and mouth disease virus (FMDV) 2A sequence was introduced between the luciferase and the DENV structural proteins to provide co-translational cleavage and release of luciferase.
The construct was based on pD2/IC-30P, which contains a full-length infectious clone encoding DENV-2 16681 in which a Q399H mutation of the envelope protein (E) was introduced that enhanced viral infection in mammalian cells using the QuikChange site-directed mutagenesis kit (Agilent Technologies) and the primers listed in Supplementary Table 1 . We gene-synthesized a fragment containing the T7-polymerase promoter sequence followed by the first 104 nucleotides of the C coding region in frame with Renilla luciferase and FMDV 2A. This fragment was PCR amplified, during which a SacI site at the 5′ end and a NheI site (present in the FMDV 2A sequence) at the 3′ end were introduced using the primers listed in Supplementary Table 1 . To create an in-frame fusion of FMDV 2A with the DENV-ORF, a second DNA fragment was amplified using pD2/IC-30P as a template with primers ( Supplementary Table 1 ) that introduced NheI and SphI restriction sites at the 5′ and 3′ ends, respectively. The two fragments were cut with the respective restriction enzymes and ligated into pD2/IC-30P cut with SacI and SphI to create pDENV-Luc. DENV-Luc virus was produced by cutting with XbaI to linearize the plasmid, transcribing pDENV-Luc in vitro using the MEGAscript T7 transcription kit (AM1334) and transfecting BHK-21 cells using Lipofectamine 2000. Filtered supernatant of transfected BHK-21 cells was used to infect Huh7.5.1 cells.
Construction of the DENV WT replicon was described previously 16 and was performed as per pDENV-Luc, except that the Renilla luciferase coding region was directly followed by the DENV ORF starting at the signal peptide preceding NS1, deleting the structural proteins. The construct was based on pD2/IC-30P, which contains a full-length infectious clone encoding DENV-2 16681 . We gene-synthesized a fragment containing the T7-polymerase promoter sequence followed by the first 102 nucleotides of the C coding region in frame with Renilla luciferase and FMDV 2A followed by the DENV ORF starting at the signal peptide preceding NS1 up to an internal HpaI site. This fragment was released by SacI (preceding the T7 promoter) and HpaI, and cloned in pD2/IC-30P in a three-point ligation with KpnI/SacI and KpnI/HpaI fragments. The primer sequences are listed in Supplementary Table 1 .
Constructs and packaging of lentivirus.
To generate a lentiviral construct expressing GFP-RRBP1, the cDNA construct (provided by A. Palazzo, University of Toronto) 21 was used as the template to generate a PCR product using primers listed in Supplementary Table 1 . The amplified PCR product was then cloned using the Gibson assembly reaction kit (New England Biolabs) into pLenti-CMV-Puro-Dest (w118-1) that was EcoRV digested. Vigilin cDNA (also known as HDLBP; MGC cDNA BC001179) was purchased from GE Dharmacon. The cDNA was amplified in two separate fragments using primers listed in Supplementary Table 1 . Both PCR fragments were cloned by Gibson Assembly (New England Biolabs) into the EcoRV-digested third-generation lentiviral Gateway destination vector pLenti-CMV-Puro-Dest(w118-1), which drives transgene expression by a CMV promoter and harbours a puromycin-resistant gene as a selectable marker.
ER-GFP was engineered according to a previously reported construct 23 . Enhanced GFP (EGFP) fused with an N-terminal signal peptide of calreticulin and a C-terminal KDEL ER retention sequence was synthesized in two fragments (Integrated DNA Technologies) and cloned by Gibson Assembly (New England Biolabs) into the pLenti-CMV-Puro-Dest(w118-1) expression vector. Lentiviral or retroviral transduction was used to create stable cell lines expressing a selected gene of interest. The respective genes of interest were cloned into the pLenti-CMV-Puro-DEST vector (w118-1; a gift from E. Campeau). Lentivirus was propagated by co-transfection of the transgene-expressing plasmid with a mixture of ∆VPR, VSV-G and pAdVAntage packaging plasmids into HEK293FT cells using FuGENE HD (Promega). The lentivirus was harvested from the supernatant and filtered through a 0.45-μm filter 48 h post-transfection. We then added 1×protamine sulphate to the lentivirus before transducing the respective cell lines overnight. Cells stably expressing the gene of interest were selected by treatment with 1-4 μg ml −1 puromycin over 2 d (InvivoGen) along with untransduced cells as negative controls. A lentivirus carrying either the mCherry (RFP) gene or the empty pLenti-CMV-Puro-DEST vector was used as a control for RRBP1 and vigilin complementation in the KO cell lines, respectively.
Quantitation of virus infectivity by qRT-PCR.
Experiments where the vRNA loads were determined by quantitative PCR (qPCR) were performed as follows: 20,000 HEK293FT, Huh7.5.1 cells or their derivatives were seeded in triplicate in 96-well plates 1 d before infection. The cells were infected the next day with the indicated virus and m.o.i. The cells were lysed at the indicated times post-infection with the lysis buffer from the Ambion Power SYBR Green Cells-to-C t kit (cat. no. 4402954). Reverse transcription and qPCR were performed according to the Cellto-C t kit instructions on a Bio-Rad CFX Connect qPCR machine. All C t values were normalized to the expression values of 18S rRNA. The qRT-PCR primers are listed in Supplementary Table 1 .
POWV infection, RNA extraction and qRT-PCR analysis.
Cells were seeded in triplicate at 1 × 10 5 cells well −1 in a 24-well plate and incubated overnight. Following incubation, the DMEM medium was aspirated and the cells were washed twice with PBS. The cells were then infected with POWV (LB strain) at an m.o.i. of 0.1. At 48 h.p.i., the POWV-infected cells were washed twice with PBS and the cells were lysed in 350 µl RLT buffer (Qiagen). Total RNA was extracted using an RNeasy mini kit (Qiagen). Complementary DNA was synthesized from 400 ng of total RNA template using the iScript cDNA synthesis kit (Bio-Rad). Primers targeting the positive-strand POWV genome ( Supplementary Table 1 ) were used to quantify the POWV transcripts as a measure of POWV genome replication relative to the 18 s rRNA gene. To determine the efficient annealing temperature for the qPCR analysis, a gradient PCR was conducted using the Phusion high-fidelity PCR master mix with HF buffer (NEB), the cDNA template prepared from POWVinfected cell RNA, the two primer pairs and the following thermocycler conditions: 94 °C for 5 min; 32 cycles of 94 °C for 15 s, 62-68 °C for 30 s and 72 °C for 2 min; and 72 °C for 7 min. Following gel electrophoresis on E-gel 1.2% agarose with SYBR Safe (Life Technologies), an annealing temperature with amplicons of the expected size with no non-specific amplification was chosen. The qPCR reactions were performed on the Applied Biosystems QuantStudio 6 Flex real-time system (Life Technologies) in Micro-Amp optical 384-well reaction plates (Life Technologies). The QuantStudio real-time PCR software (v1.3) and the ΔΔC t method were used to calculate the relative numbers of POWV transcripts.
Detection of DENV proteins using immunoblotting.
Wild-type Huh7.5.1 cells and their derivatives were seeded in quadruplet at 1 × 10 5 cells well −1 in a 24-well plate and incubated overnight. The cells were then infected with DENV-2 429557 at an m.o.i. of 0.1. The cells were harvested 72 h post-infection using RIPA buffer (TEKNOVA) supplemented with Laemmli sample buffer (Bio-Rad) and 5% β-mercaptoethanol (Bio-Rad). The cell lysates were then boiled for 10 min and separated by SDS-PAGE on pre-cast 4-15% polyacrylamide gels (Bio-Rad) in a Bio-Rad Mini-PROTEAN gel system. Proteins were transferred onto PVDF membranes. The PVDF membranes were blocked with PBS buffer containing 0.1% Tween 20 and 5% non-fat milk. The blocked membranes were then incubated overnight with primary antibody diluted in blocking buffer on a rocker at 4 °C. The primary antibodies were subsequently detected by incubating the membranes for 1 h at room temperature with secondary anti-mouse or anti-rabbit antibodies conjugated to horseradish peroxidase (Genetex; 1:5,000 dilution). The antibodybound proteins were detected by incubating with SuperSignal West Pico PLUS chemiluminescent substrate or Dura Extended duration substrate (Thermo Fisher Scientific) peroxide solutions and visualized on a Bio-Rad ChemiDoc Touch imaging system. The following primary antibodies were used: anti-prM (Genetex, GTX128092) at a dilution of 1:2,500, anti-NS3 (Genetex, GTX124252) at a dilution of 1:2,500 and anti-GAPDH (Genetex, GTX 627408) at dilution of 1:5,000.
Luciferase reporter virus and DENV replicon luciferase assays.
For the luciferase reporter virus assays, HEK293FT or Huh7.5.1 cells were seeded in 96-well plates (20,000 cells well −1 and 10,000 cells well −1 , respectively) and infected with DENV-Luc or ZIKV-Luc at an m.o.i. of 0.01. The final concentration of MK0608 was always 50 µM in this study. Cells were incubated with the viruses at 37 °C with 5% CO 2 and the cell lysates were harvested at the indicated times. Luciferase expression was measured using the Renilla luciferase assay system (Promega, E2820). The cells were lysed using Renilla lysis buffer, and luciferase activity was measured by the addition of the substrate and luciferase readings were immediately taken using Glomax 20/20 luminometer with a 5 s integration time.
For the Renilla luciferase-expressing DENV replicon assays, the DENVreplicon plasmid was linearized using XbaI restriction enzyme. Replicon RNA was generated using the MEGAscript T7 high yield transcription kit (Ambion, AM1334) with the reaction containing the 5 mM m 7 G(5′)ppp(5′)G RNA cap structure analogue (NEB, S1405S). The resulting RNA was purified by sodiumacetate and ethanol precipitation. HEK293FT cells were washed twice with PBS and resuspended in electroporation buffer (Teknova, E0399). The purified replicon RNA (3 μg) was mixed with cells and the cells were electroporated using the Bio-Rad Gene Pulser Xcell electroporator with the square wave protocol. The electroporated cells were resuspended in cell culture medium without antibiotics and plated into 96-well plates. Luciferase expression was measured using the Renilla luciferase assay system (Promega E2820). The cells were lysed at the indicated times using Renilla lysis buffer, and the luciferase activity was measured by the addition of substrate and luciferase readings were taken immediately using Glomax 20/20 luminometer using a 5 s integration time.
irCLIP. Infrared crosslinking and immunoprecipitation was performed as previously reported 25 . A total of 7.5 × 10 6 Huh7.5.1 cells were seeded and infected the next day with DENV-2 16681 or ZIKV PRVABC59 at an m.o.i. of 0.1. The infected cells were UV crosslinked at 48 h.p.i. to a total of 0.35 J cm −2 . Whole-cell lysates were generated in CLIP lysis buffer (50 mM HEPES, 200 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% NP-40, 0.2% Triton X-100 and 0.5% N-lauroylsarcosine) and briefly sonicated using a probe-tip Branson sonicator to solubilize the chromatin. Each experiment was normalized to the total protein amount, typically 1 mg, and partially digested with RNase A (Thermo Fisher Scientific, EN0531) for 10 min at 37 °C and then quenched on ice. The RRBP1 (Bethyl, A303-996A), vigilin (Bethyl, A303-971A) and IgG (Thermo Fisher Scientific, 02-6102) immunoprecipitations were performed using 15 μg of each antibody with 50 μl Protein A Dynabeads (Thermo Fisher Scientific) for 8 h at 4 °C with rotation. The samples were sequentially washed (1 min each wash) at 25 °C in 1-ml volumes as follows: 1×high stringency buffer (15 mM Tris-HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, 120 mM NaCl and 25 mM KCl), 1×high salt buffer (15 mM Tris-HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate and 1 M NaCl) and 2×NT2 buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl 2 and 0.05% NP-40). The RNA-protein complexes were dephosphorylated after the NT2 washes with T4 PNK (NEB) for 45 min in an Eppendorf Thermomixer at 37 °C, 15 s at 1,400 r.p.m., 90 s of rest in a 30 μl reaction, pH 6.5, containing 10 U T4 PNK, 0.1 μl SUPERase-IN (Thermo Fisher Scientific) and 6 μl PEG 400 (16.7% final). The dephosphorylated RNA-protein complexes were then rinsed once with NT2 buffer and 3′-end ligated overnight with T4 RNA ligase 1 (NEB) in an Eppendorf Thermomixer at 16 °C, 15 s at 1,400 r.p.m., 90 s of rest in a 60 μl reaction containing 10 U T4 RNA ligase, 1.5 pmol pre-adenylated-IR800-3′ biotin DNA-adaptor, 0.1 μl SUPERase-IN and 6 μl of PEG 400 (16.7% final). The following day, the samples were rinsed once with 500 μl NT2 buffer and resuspended in 30 μl of 20 mM dithiothreitol (DTT) and 1×LDS (Thermo Fisher Scientific) in NT2 buffer. The samples were heated to 75 °C for 10 min and the released RNA-protein complexes were separated by 4-12% bis-Tris SDS-PAGE (1.0 mm × 12 well) at 200 V for 45 min. The resolved ribonucleoprotein complexes were wet-transferred to nitrocellulose at 550 mA for 45 min at 4 °C.
The nitrocellulose membranes were imaged using an Odyssey CLx scanner (LiCor); the RBP-RNA complexes were excised using scalpels and the RNA was recovered by adding 0.1 ml Proteinase K reaction buffer (100 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA and 0.2% SDS) and 5 μl 20 mg ml −1 Proteinase K (Thermo Fisher Scientific). The proteins were digested for 60 min at 50 °C in an Eppendorf Thermomixer. Next, 200 μl saturated-phenol-chloroform pH 6.7 was added to each tube and incubated for 10 min at 37 °C in an Eppendorf Thermomixer with 1,400 r.p.m. The tubes were briefly centrifuged and the entire contents transferred to a 2 ml Heavy Phase Lock Gel (5Prime, cat. no. 2302830). The samples were centrifuged for 2 min at >13,000 r.p.m. The aqueous layer was re-extracted with 1 ml chloroform (inverting ten times to mix; no vortexing) in the same 2 ml Phase Lock Gel tube and centrifuged for 2 min at >13,000 r.p.m. The aqueous layer was then transferred to a new 2 ml Heavy Phase Lock Gel tube and extracted again with an additional 1 ml chloroform. After a 2 min centrifugation at >13,000 r.p.m., the aqueous layer was transferred to a siliconized 1.5 ml tube and precipitated overnight at −20 °C with the addition of 10 μl 5 M NaCl, 3 μl linear polyacrylamide (Thermo Fisher Scientific) and 0.8 ml 100% ethanol. The RNA fragments were pelleted at >13,000 r.p.m. for 45 min at 4 °C, washed once with 1 ml ice-cold 75% ethanol and air dried.
The RNA pellets were resuspended in 12 μl water; 1 μl of 3 μM cDNA and 1 μl of 10 mM dNTPs were added, heated to 70 °C for 5 min and then rapidly cooled to 4 °C. We then added cDNA master mix (4 μl 5×SuperScript IV (SSIV) buffer, 1 μl 100 mM DTT and 1 μl SuperScript IV; 6 μl total) to the annealed RNA and incubated for 30 min at 55 °C. The cDNA:RNA hybrids were captured by the addition of 5 μl MyOne Streptavidin C1 Dynabeads (Thermo Fisher Scientific), which had been rinsed and suspended in 50 μl Biotin IP buffer (100 mM Tris, pH 7.5, 1 M NaCl, 1 mM EDTA and 0.1% Tween), and end-over-end rotation for 45 min at room temperature. The beads were placed on a 96-well magnet and washed twice sequentially with 100 μl Biotin IP buffer and 100 μl ice-cold 1 × PBS. The beads were resuspended in 10 μl cDNA elution buffer (8.25 μl water, 1 μl of 1 μM P3 short oligo and 0.75 μl of 50 mM MnCl 2 ) and heated to 95 °C for 10 min. Subsequently, samples were cooled down at a rate of 0.1 °C s −1 to 60 °C. Next, 5 μl circularization reaction buffer (3.3 μl water, 1.5 μl 10×Circligase II buffer and 0.5 μl Circligase II; Epicentre) was added. The cDNA was circularized for 2 h at 60 °C, followed by purification with 30 μl AMPure XP beads (Beckman Coulter) and 75 μl isopropanol. The samples were incubated for 20 min at 25 °C, washed twice with 100 μl 80% ethanol, air dried for 5 min and eluted in 14 μl water. Elution took place at 95 °C for 3 min and the samples were immediately transferred to a 96-well magnet. The eluted cDNA was transferred to a new PCR tube containing 15 μl 2×Phusion HF-PCR master mix (NEB), 0.5 μl of 30 μM P3/P6 PCR oligo mix and 0.5 μl 15×SYBR Green I (Thermo Fisher Scientific). Real-time qPCR was then performed as follows: 98 °C for 2 min; 15 cycles of 98 °C for 15 s, 65 °C for 30 s and 72 °C for 30 s, with data acquisition set to the 72 °C extension step. The PCR reactions were cleaned by adding 4.5 μl isopropanol, 54 μl AMPure XP beads and incubating for 10 min. The beads were washed once with 80% ethanol, dried for 5 min and eluted in 15 μl water. Illumina flow cell adaptors were added by adding 15 μl 2×Phusion HF-PCR master mix and 0.4 μl P3solexa/P6solexa oligo mix and amplified as follows: 98 °C for 2 min, followed by three cycles of 98 °C for 15 s, 65 °C for 30 s and 72 °C for 30 s. The final libraries were purified with the addition of 48 μl AMPure XP beads and incubation for 5 min. The beads were washed twice with 70% ethanol, dried for 5 min and eluted in 20 μl water. The libraries (1-2 μl) were quantitated using a HS-DNA Bioanalyzer. The samples were deep sequenced on the Illumina NextSeq machine (single-end, no index, high-output, 75-base-pair cycle run).
Analysis of irCLIP data. The irCLIP data were processed using the FAST-iCLIP pipeline (https://github.com/ChangLab/FAST-iCLIP/tree/lite). PCR duplicates were removed using unique molecular identifiers in the RT primer region. The adaptor and barcode sequences were trimmed and reads were mapped step-wise to viral (DENV or ZIKV), repetitive and finally non-repetitive (GRCh38) genomes. Bowtie2 indexes were generated using the 'bowtie2-build' command in Bowtie2 for the DENV (KU725663.1) and ZIKV (KU501215.1) RNA genome sequences. The specific parameters used for the FAST-iCLIP pipeline were as follows: -f 18 (trims 17 nt from the 5′ end of the read), -l 16 (includes all reads longer than 16 nt), -bm 29 (minimum MAPQ score from bowtie2 of 29 is required for mapping; unique mapping only), -tr 2,3 (repetitive genome) and -tn 2,3 (non-repetitive genome) RT stop intersection (n,m; where n = replicate number and m = number of unique RT stops required per n replicates). Using the -tr/tn 2,3 parameters, a minimum of six RT stops are required to support any single nucleotide identified as a crosslinking site. For the Gene Ontology analysis, the top 25% of the irCLIPbound genes were analysed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool (https://david.ncifcrf.gov/tools.jsp). The peaks of the RT stops were called on the biologically replicated intersection of the RT stop positions using iCount peaks (http://icount.readthedocs.io/en/latest/). The command line was as follows: iCount peaks gencode.v21.annotation.segment. gtf RTstop_input.bed Out_iCpeaks.bed -scores Out_iCpeaksScores.tsv. Regions from 'Out_iCpeaks.bed' were then annotated with HOMER (http://homer.ucsd. edu/homer/) using the following command: annotatePeaks.pl Out_iCpeaks.bed hg38 > Out_iCpeaks_hg38_HOMERanno.txt -annStats Out_iCpeaks_hg38_ HOMERanno_stats.txt.
CLIP mass spectrometry. Cells were grown and UV crosslinked, and lysates were generated, RNase A treated, immunoprecipitated and washed as described for irCLIP. No dephosphorylation or RNA ligation took place, but the RBP-RNA complexes were denatured and run in SDS-PAGE gels as per the irCLIP procedure. After a complete run of the SDS-PAGE, the gels were fixed and stained with a Colloidal blue staining kit (Thermo Fisher Scientific) as per the manufacturer's instructions. The stained gels were visualized with the Odyssey CLx scanner and regions of each lane were excised based on where the predicted RBP-RNA complex would migrate.
The gel slices were prepared for mass spectrometry by sequentially rinsing in 200 μl HPLC-grade water, 100% acetonitrile (ACN; Thermo Fisher Scientific) and 50 mM ammonium bicarbonate (AmBic). The samples were reduced by adding 200 μl of 5 mM DTT in 50 mM AmBic and incubating at 65 °C for 35 min. The reduction buffer was discarded and the samples were cooled to room temperature. Alkylation was achieved by adding 200 μl of 25 mM iodoacetamide in 50 mM AmBic for 20 min at 25 °C in the dark. The alkylation buffer was discarded; the samples were rinsed once in 200 μl of 50 mM AmBic and then washed twice for 10 min each in 200 μl freshly prepared 50% ACN in 50 mM AmBic. After each wash, the supernatant was discarded and the samples were dried for 3 h using a SpeedVac. Once dry, the proteins were digested by adding 100 ng trypsin in 200 μl of 50 mM AmBic for 16 h at 37 °C. The samples were subsequently acidified by adding formic acid to a final concentration of 2.5% and incubating at 37 °C for 45 min. Finally, the samples were desalted using HyperSep filter plates with a 5-7 μl bed volume (Thermo Fisher Scientific) following the manufacturer's instructions. The samples were eluted three times in 100 μl 80% ACN in 2.5% formic acid, dried on a SpeedVac and resuspended in 10 μl 0.1% formic acid for mass-spectrometry analysis. Desalted peptides were analysed by online capillary nanoLC-MS/MS. The samples were separated using a 20-cm reversed phase column fabricated in-house (inner diameter of 100 µm, packed with ReproSil-Pur C18-AQ 3.0 μm resin (Dr. Maisch GmbH)), which was equipped with a laser-pulled nanoelectrospray emitter tip. Peptides were eluted at a flow rate of 400 nl min −1 using a two-step linear gradient of 2-25% buffer B in 70 min and 25-40% B in 20 min (buffer A: 0.2% formic acid and 5% DMSO in water; buffer B: 0.2% formic acid and 5% DMSO in ACN) in an Eksigent ekspert nanoLC-425 system (AB Sciex). The peptides were ionized with electrospray ionization into an Orbitrap Elite Hybrid Ion Trap-Orbitrap mass spectrometer (Thermo Fisher Scientific). The instrument method parameters were as follows: MS1 resolution, 60,000 at 400 m/z; scan range, 340−1,600 m/z. The top-20 most-abundant ions were subjected to collisioninduced dissociation with a normalized collision energy of 35%, activation q of 0.25 and precursor isolation width of 2 m/z. Dynamic exclusion was enabled with a repeat count of one, a repeat duration of 30 s and an exclusion duration of 20 s. FASTA sequences of the DENV (accession number: ANG57776) or ZIKV (accession number: AOR51315) proteomes were downloaded and appended to the human proteome (UniProt accession number: UP000005640) for each database search. RAW files were searched using Byonic (Protein Metrics) with the following parameters: semi-specific cleavage specificity at the C-terminal site of R and K, allowing for two missed cleavages, precursor mass tolerance of 12 ppm and fragment ion mass tolerance of 0.4 ppm. Methionine oxidation, asparagine deamidation and N-term acetylation were set as variable modifications. Cysteine carbamidomethylation was set as a fixed modification. Peptide hits were filtered using a 1% FDR.
A custom Python script was written to merge technical and biological replicates across the different ChIRP-MS experiments (https://github.com/jasonkli/ MS-Analysis). First, .xls output files from Byonic were analysed for spectra of each protein identified. The total number of spectra, excluding any spectra with a quality score below 100, were counted and printed into new .xls files, one for each set of experiments. For each set of technical replicates, the number of spectra for each protein is summed across replicates and normalized by dividing by the total number of spectra from all reads in the set. These normalized values were then scaled with a factor of 1,000 for readability. Next, we consolidated data across biological replicates. We filtered identified proteins so that a given protein was required to be present with at least one spectrum in each biological replicate. The normalized spectra of the surviving protein IDs were then averaged across the biological replicates. Finally, a combined table was generated across all experimental data as per the previous steps. For each protein identified, we output the following information: common gene name, UniProt ID, comma-separated values of the raw spectra from each technical and biological replicate, the average normalized spectra from each experiment (with an added correction factor of one to avoid any zeroes for subsequent analyses), the averaged normalized spectra divided by the number of amino acids in the protein and the total amino acids in that protein.
Comprehensive identification of RNA-binding proteins by mass spectrometry. DENV-, ZIKV-and RV-targeting probes were designed using online tools available at https://www.biosearchtech.com/stellaris, with a repeat masking setting of three and even coverage of the whole transcript. The full probe sequences are available in Supplementary Table 1 . Oligos were synthesized with 3′ biotin-TEG modification at the Stanford Protein and Nucleic Acid Facility.
ChIRP-MS was performed largely as described in Chu and colleagues 9 . Huh7.5.1 cells (9 × 7.5 × 10 6 ) were seeded and infected the following day with DENV-2 (16681 strain-Hap1 adapted), ZIKV PRVABC59 at an m.o.i. of 0.1 or mock-treated in triplicate (3 × 3 = 9 flasks per condition). For RV, 2 × 7.5 × 10 6 H1-HeLa cells were seeded and infected the next day at an m.o.i. of 1 or mock infected. The medium was aspirated 48 h after infection, and the cells were rinsed once with 10 ml PBS per flask, trypsinized, pelleted at 1,400 r.p.m. for 5 min and washed twice with PBS. The cells were then resuspended in 3% formaldehyde containing PBS and rocked for 30 min at 25 °C. Chemical crosslinking was then stopped by the addition of glycine to a final concentration of 125 mM for 5 min at 25 °C. The crosslinked cells were pelleted at 2,000 r.p.m. for 5 min (the supernatant was discarded) and flash frozen at −80 °C for storage. Lysate was generated by resuspending the cell pellets in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.0, 10 mM EDTA and 1% SDS) per 100 mg cell pellet (pellet volume of about 100 μl). The lysates were sonicated using a focused-ultrasonicator (Covaris, E220) until the average RNA length was 500 nucleotides, as determined by agarose gel analysis, and stored at −80 °C. Stored lysates were thawed on ice; 2 ml of freshly prepared ChIRP hybridization buffer (750 mM NaCl, 1% SDS, 50 mM Tris-HCl, pH 7.0, 1 mM EDTA and 15% formamide) was added for every millilitre of sonicated lysate and the lysates were pre-cleared by adding 30 μl washed MyOne C1 beads per 1 ml lysate at 37 °C for 30 min on rotation. Beads were removed twice from the lysate using a magnetic stand; for this and all subsequent magnetic stand steps we allowed >1 min of separation before removing any supernatant. Next, 1.5 μl of 100 μM ChIRP Probe Pools was added per millilitre of lysate. ChIRP Probe Pools ( Supplementary Table 1 ) for control, DENV or ZIKV enrichments were made by mixing equal volumes of 99 (DENV + ZIKV), 50 (DENV) or 49 (ZIKV) individual antisense oligos at 100 μM (final concentration of 1.01, 2 and 2.04 μM for each probe, respectively). The RV pool was made by mixing equal volumes of 50 individual antisense oligos targeting the RV genome at 100 μM (2 μM final concentration for each probe) and was used for the RV-uninfected control. After mixing, hybridization took place on rotation for 16 h at 37 °C. Subsequently, 150 μl washed MyOne C1 beads per millilitre of lysate were added to each sample and incubated on rotation for 45 min at 37 °C. The enriched material was collected on the beads with a magnetic stand and the beads were washed 5 × 2 min in 1 ml ChIRP wash buffer (2×SSC solution (Thermo Fisher Scientific) and 0.5% SDS) at 37 °C. To elute the enriched proteins, the beads were collected on a magnetic stand, resuspended in ChIRP biotin elution buffer (12.5 mM biotin, 7.5 mM HEPES, pH 7.9, 75 mM NaCl, 1.5 mM EDTA, 0.15% SDS, 0.075% sarkosyl and 0.02% sodium deoxycholate), mixed at 25 °C for 20 min on rotation and at 65 °C for 15 min with shaking. The eluent was transferred to a fresh tube and the beads were eluted again. The two eluents were pooled (about 1,200 μl) and residual beads were removed again using the magnetic stand. Trichloroacetic acid (25% of the total volume; 300 μl) was added to the clean eluent, vortexed and the samples were then placed overnight at 4 °C for precipitation. The next day, the proteins were pelleted at 21,000 g at 4 °C for 45 min. The supernatant was carefully removed and the protein pellets were washed once with ice-cold acetone. The samples were spun at 21,000 r.c.f. for 5 min at 4 °C. The acetone supernatant was removed, the tubes were briefly centrifuged again and-after the removal of the residual acetone-were left to air-dry on the bench top. The proteins were then solubilized in 1×LDS buffer in NT2 with 20 mM DTT and boiled at 95 °C for 30 min with occasional mixing for reverse-crosslinking.
The protein samples were size-separated on bis-Tris SDS-PAGE gels (Bio-Rad), fixed and stained with colloidal blue, and prepared for mass-spectrometry analysis as described for 'CLIP mass spectrometry' . Biological triplicates were performed for each uninfected control, DENV or ZIKV ChIRP-MS. Each replicate was cut into four slices in the SDS-PAGE and prepared independently (total of four mass spectrometry runs per biological replicate). For RV ChIRP-MS, one replicate of RV-infected and uninfected H1-HeLa cells was used and split across four independent gel slices. ChIRP-MS data were searched with Byonic and processed as per the custom python script described in 'CLIP mass spectrometry' . Principal component analysis of the individual biological replicates was accomplished using the ClusterVis tool (http://biit.cs.ut.ee/clustvis/) 49 . High-confidence host factors associated with vRNAs were defined as being enriched more than twofold over the uninfected cell ChIRP. We used the SAINT scoring system 50 , specifically the SAINTq software (http://saint-apms.sourceforge.net/Main.html), to apply a statistical confidence filter to refine the ChIRP-MS hits. Individual biological triplicates for mock-, DENV-or ZIKV-infected ChIRP-MS hits were used as input data for the SAINTq software with default settings for the FDR calculations.
ChIRP qRT-PCR. Cells were grown, infected, crosslinked and sonicated as described earlier. After sonication, 1% of the lysate was removed and saved as an 'input' sample. The lysates were again processed as earlier for pre-clearing, hybridization, MyOne C1 capture and bead washing. After washing, 1% of each sample was removed as an 'enriched' fraction. The enriched fractions were collected while the MyOne C1 beads were fully resuspended in ChIRP wash buffer. ChIRP PK buffer (10 mM Tris-HCl pH 7.0, 100 mM NaCl, 1 mM EDTA, 0.2% SDS) was added to the input and enriched samples to a final volume of 95 μl. Proteinase K (5 μl of 20 mg ml −1 ) was then added with shaking at 55 °C for 45 min to digest the protein. RNA was extracted by adding 500 μl TRIzol (Thermo Fisher Scientific), incubating at 55 °C for 5 min and then adding 100 μl chloroform. After mixing each sample by vortexing for 7 s, the samples were incubated at 25 °C for 5 min and then centrifuged at 12,000 r.p.m. for 15 min at 4 °C. The aqueous layer was carefully removed from each sample, mixed with two volumes of 100% ethanol and purified using a RNA Clean & Concentrator-25 kit (Zymo Research) as per the manufacturer's instructions. All RNA samples were DNase treated with the Turbo DNA-free kit (Thermo Fisher Scientific). SuperScript VILO (Thermo Fisher Scientific) was used to generate cDNA according to manufacturer's instructions. The qPCR analyses were performed on the CFX96 Touch real-time PCR detection system (Bio-Rad). All of the primers used are provided in Supplementary Table 1 .
ChIRP and RNA Bioanalyzer. Cells were grown, infected and the RNA was harvested as described earlier. This RNA was either analysed directly using a RNA Pico Bioanalyzer chip (Agilent Technologies) or by denaturing gel electrophoresis. A formaldehyde-agarose gel was made using the NorthernMax kit (Thermo Fisher Scientific) as per the manufacturer's protocol. The RNA samples were denatured in 0.5×Gel Loading Buffer II (Thermo Fisher Scientific) and 1×SybrGold (Thermo Fisher Scientific) at 55 °C for 10 min, cooled on ice for 3 min and then loaded into the gel. After running at 110 V for 35 min, the RNA was imaged using a UV transilluminator.
RNA-seq from irCLIP samples. Input material for RNA-seq was obtained from the same lysates generated for the irCLIP experiment. After lysis and sonication, as described earlier, 100 μl lysate from each biological duplicate of the uninfected and DENV-or ZIKV-infected cells was removed. Proteins were digested and RNA extracted with Proteinase K and TRIzol as described in the 'ChIRP qRT-PCR' section. Ribosomal RNA was depleted using a RiboMinus transcriptome isolation kit (human/mouse; Thermo Fisher Scientific) as per the manufacturer's instructions starting with 5 μg total RNA per sample. Samples depleted of rRNA were fragmented using the RNA fragmentation reagent (Thermo Fisher Scientific) at 90 °C for 30 s. After fragmentation, the RNA samples were purified using a RNA Clean & Concentrator-5 kit (Zymo Research) as described in the 'ChIRP qRT-PCR' section and the RNA was eluted in 5 μl water. The RNA 3′ ends were repaired by the addition of 0.5 μl 10×T4 PNK buffer (New England Biolabs), 1 μl T4 PNK, 1 μl FastAP (Thermo Fisher Scientific), 1 μl RiboLock (Thermo Fisher Scientific) and 1.5 μl water for 45 min at 37 °C. Next, a 3′-adaptor was ligated to the RNA samples by directly adding 1 μl 10×T4-RNL1 buffer (New England Biolabs), 1 μl T4-RLN1 (New England Biolabs), 1 μl of 100 mM DTT, 0.75 μl of 3 μM irCLIP 3′-adaptor and 6 μl 50% PEG8000 (New England Biolabs) for 4 h at 25 °C. After the completion of the ligation reaction, unligated 3′-adaptors were digested by directly adding 2.5 μl Rec-Jf (New England Biolabs), 1.25 μl 5′-deadenylase (Epicentre), 3 μl 10×5′-deadenylase buffer (Epicentre) and incubating for 1 h at 37 °C. The samples were purified using a RNA Clean & Concentrator-5 kit (Zymo Research) as above. The ligated and purified RNA samples were processed further into double-stranded DNA libraries as per the final steps of the irCLIP procedure described earlier. The samples were sequenced on the NextSeq 500 platform (Illumina) after library quantification and pooling. Data were processed for mapping as per the irCLIP pipeline; however, RT stops were not isolated after mapping. Instead the featureCount tool of the Subread package (version 1.6.0) was used to count the aligned reads supporting transcripts annotated from Gencode Release 26 (GRCh38; https://www.gencodegenes.org/ releases/26.html). Genes supported by at least ten reads in a biological replicate were considered as expressed. RNA-seq counts were normalized to the total counts for all expressed genes in each sample to produce counts-per-million reads. To calculate the enrichment of ER-annotated genes, a counts-per-million cut-off of 1.0 was set for genes identified in the uninfected RNA-seq (18, 199) and then intersected with ERannotated gene names from Uniprot (Supplementary Table 4 ). A two-sided Fisher's exact test was used to determine statistical enrichment.
Immunofluorescence and RNA fluorescence in situ hybridization. Huh7.5.1 cells (80,000) were seeded on poly-lysine-coated glass cover slips in a 24-well format.
The cells were infected the following day with either DENV-2 or ZIKV (Puerto Rico) at an m.o.i. of 1 for 24 h. The cells were fixed with 4% formaldehyde (Sigma), washed with PBS and permeabilized using the Immunofluorescence application solution kit according to the manufacturer's recommendations (Cell Signaling, cat. no. 12727). The ER-GFP marker was transfected into Huh7.5.1 cells using Lipofectamine 3000 (Thermo Fisher Scientific) according to the manufacturer's guidelines. At 48 h post-transfection, the cells were fixed with 4% formaldehyde for 30 min at room temperature, washed with PBS and permeabilized with 1% NP-40 for 5 min at room temperature. The cells were incubated with antibodies against RRBP1 (Bethyl, A303-996A; 1:100 dilution), vigilin (Bethyl, A303-971A; 1:20 dilution), GFP (Thermo Fisher Scientific, MA5-15256; 1:100 dilution) for 90 min at room temperature. The cells were washed twice with PBS and stained with secondary Alexa Fluor antibodies 488 nm, 594 nm, 647 nm (Thermo Fisher Scientific, cat. nos A-11034, R37117 and A31573) at a 1:200 dilution for 1 h at room temperature. RNA probes that detect the positive-strand vRNA for DENV and ZIKV were purchased from Affymetrix. The vRNAs were then stained using RNA probes in conjunction with branched-DNA amplification to generate single molecule detection of vRNA as per the manufacturer's protocol (ViewRNA Cell Plus Assay, cat. no. 88-19000-99). Finally, coverslips were mounted onto glass slides using PermaFluor (Thermo Fisher Scientific) containing 4′,6-diamidino-2-phenylindole (DAPI; Affymetrix). The cells were visualized on a Nikon AR1 or Leica SP8 confocal microscope. At least 30 cells were analysed for each condition using the ImageJ colocalization algorithm COLOC2 (https://github.com/fiji/ Colocalisation_Analysis/releases/tag/Colocalisation_Analysis-3.0.0). Pearson's correlation scores for colocalization were plotted to determine the level of colocalization between the vRNAs and either the costained host proteins or DAPI. Subcellular fractionation. Huh7.5.1 cells (300,000) were washed twice with cold PBS. The cells were then separated into their cytosolic and ER compartments as previously described 24 . Briefly, the cytosol fraction was extracted by the addition of a buffer containing 0.03% digitonin, 110 mM potassium acetate, 25 mM K-HEPES pH 7.2, 15 mM MgCl 2 and 4 mM CaCl 2 to the dish and incubated on ice for 5 min. The supernatant with the buffer containing the cytosolic contents was collected after low-speed centrifugation (600 r.c.f. for 5 min) and the cells were washed with the same buffer containing 0.0015% digitonin. The first lysis and the wash were combined and represent the cytosolic contents of the cell. The membrane fraction that contained the ER membranes was then collected by lysis of the digitonin-extracted cell pellet with an ER lysis buffer containing 2% n-dodecylβ-d-maltoside, 200 mM potassium acetate, 25 mM K-HEPES pH 7.2, 15 mM MgCl 2 and 4 mM CaCl 2 . Western blot analysis of the two different fractions was then performed with antibodies against RRBP1, vigilin, the cytoplasmic markers GAPDH (Genetex, GTX 627408) and tubulin (Abcam ab97872), and the ER marker RPN1 (Bethyl Laboratories, A305-026A).
Native co-IP. Huh7.5.1 cells were seeded in six-well plates and infected with DENV-2 at an m.o.i. of 0.1 or with no virus as described earlier. Protein-G beads were pre-conjugated to rabbit-IgG (Thermo Fisher Scientific, 02-6102) or anti-RRBP1 (Bethyl, A303-996A) antibodies; 3 μg antibody and 10 μl Protein G beads were used per immunoprecipitation reaction. After 48 h of infection, protein lysate was generated by adding 650 μl co-IP lysis buffer (10 mM HEPES, 2 mM MgCl 2 , 10 mM KCl, 0.5% NP-40, 0.5 mM EDTA and 150 mM NaCl) to each well, disrupting the cells with a cell lifter and incubating the lysate at 4 °C for 30 min. The lysates were cleared by centrifugation at 5,200 r.c.f for 5 min at 4 °C. The clarified lysates (100 μl) from the no-virus or DENV-2 infections were diluted in 400 μl co-IP lysis buffer (500 μl final), to which the pre-conjugated antibody-Protein-G beads were added for 3 h at 4 °C with rotation. Each condition was performed in biological triplicates. RNase-treated samples were generated by adding 1 μl of 1 μg μl −1 RNase A to the lysate during the immunoprecipitation at 4 °C. After 3 h, each sample was washed three times with 750 μl co-IP lysis buffer and once with 750 μl NT2 buffer. The enriched proteins were subsequently analysed by western blotting.
Genome-scale CRISPR-Cas9 KO screens.
Genome-scale CRISPR-Cas9 mutagenized Huh7.5.1 cells were generated as previously described 16, 51 . In brief, stable Cas9-expressing Huh7.5.1 WT cells were engineered by transducing lentiCas9-Blast and selected using blasticidin. Subsequently, 300 × 10 6 Cas9-expressing Huh7.5.1 cells were transduced with the lentiGuide-Puro from the GeCKOv2 library 51 at an m.o.i. of 0.3. Puromycin-resistant cells were selected, pooled and expanded. These mutagenized cells were ready to be used for CRISPR genetic screens at 10 d post-transduction. Mutagenized cells-65 × Table 1 ). The PCR products were further 1 nature research | reporting summary
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code Data collection irCLIP data were collected in biological duplicate and generated on Illumina NextSeq 500 instrument. ChIRP-MS data were collected in biological triplicate and generated on a Thermo Orbitrap Fusion instrument. CRISPR-Cas9 KO screens and Haploid Genetic screens data were generated on Illumina NextSeq 500 instrument.
Data analysis
-MAGeCK (version 0.5.4) (PMID 25476605) was used for CRISPR-Cas9 screen analyses.
-Deep sequencing data from Haploid Genetic Screen was analyzed as previously described (PMID: 27383987). -ImageJ colocalization algorithm COLOC2 (https://github.com/fiji/Colocalisation_Analysis/releases/tag/Colocalisation_Analysis-3.0.0) was used to quantify colocalization between proteins and/or viral RNAs. -SAINTq software (http://saint-apms.sourceforge.net/Main.html) was used to apply a statistical confidence filter to refine the ChIRP-MS hits -The Database for Annotation, Visualization and Integrated Discovery, DAVID (https://david.ncifcrf.gov/tools.jsp) was used for gene ontology (GO) analysis.
-irCLIP data were analyzed using a custom script available at: https://github.com/ChangLab/FAST-iCLIP/tree/lite. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
